arrow
返回
W

Wen-Ming Chen

National Kaohsiung University of Science and Technology

37H指数
533论文数
9.5K被引数
收录论文 64
发表时间
Perspectives on anti-BCMA bispecific antibodies use in multiple myeloma–experience from Asian countries关于抗BCMA双特异性抗体在多发性骨髓瘤中的使用——来自亚洲国家的经验
err2025-10-11
err0
PREAI
errCinnie Soekojo; Shimin Jasmine Chung; Ming-Tao Tsai; Wenming Chen; Jeffrey Huang; Jin Seok Kim; Dong-Gun Lee; Chang Ki Min; Kazuhito Suzuki; Subramanian Swaminathan; Hiroyuki Takamatsu; Daryl Tan; Uday Yanamandra; Chandramouli Nagarajan; Wee Joo Chng
err分享
err收藏
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myelomaII期研究:zevorcabtagene autoleucel,一种靶向BCMA的全人源CAR T细胞疗法,在复发/难治性多发性骨髓瘤患者中的应用
err2025-10-02
err0
errOAAI
errWenming Chen; Chengcheng Fu; Baijun Fang; Aibin Liang; Zhongjun Xia; Yanjuan He; Jin Lu; Hui Liu; Ming Hou; Zhen Cai; Wei Yang; Siguo Hao; Songfu Jiang; Hongmei Jing; Jing Liu; Xin Du; Rong Fu; Heng Mei; Zunmin Zhu; Yanli Yang; Hong Liu; Xingxing Meng; Nishanthan Rajakumaraswamy; Daijing Yuan; Huamao Wang; Zonghai Li
err分享
err收藏
Subgroup Analyses of Phase 2 Study: Evaluating the Efficacy of Fully Human BCMA-Targeting CAR T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple MyelomaII期研究的亚组分析:评估全人源BCMA靶向CAR T细胞(Zevorcabtagene autoleucel)在复发/难治性多发性骨髓瘤患者中的疗效
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; Jiang, Songfu; Jing, Hongmei; Liu, Jing; Du, Xin; Fu, Rong; Mei, Heng; Zhu, Zunmin; Yang, Yanli; Liu, Hong; Meng, Xingxing; Rajakumaraswamy, Nishanthan; Zheng, Wei; Wang, Huamao; Li, Zonghai
err分享
err收藏
Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study伊沙佐米为基础的方案作为初治新诊断多发性骨髓瘤患者的中国一线治疗:Infinite研究真实世界数据
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCheng, Fu Cheng; Jin, Song; Zhuang, Junling; Zhou, Xin; Zhou, Fan; Li, Yuhua; Ding, Kaiyang; Niu, Ting; Chen, Wenming; Fang, Baijun; Chen, Li-Li; Fu, Rong; Zhang, Hao; Fu, Jiaping; Wang, Xiuju; Liu, Sha; Li, Lin; Wu, Depei
err分享
err收藏
SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 TrialSG301,一种新型抗CD38单克隆抗体,在复发/难治性多发性骨髓瘤患者中的研究:一项首次人体、多中心、I期临床试验
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errTian, Ying; Zhou, Keshu; Lin, Quande; Qian, Wenbin; Yang, Wei; Sao, Li; Yuan, Guolin; Yan, Xiaojing; Ma, Liangming; Zhou, Xin; Liu, Lihong; Zhu, Fangbing; Zuo, Xuelan; Du, Xin; Ji, Xu; Zhang, Xuzhao; Shen, Jing; Zhou, Hai; Li, Na; Chen, Wenming
err分享
err收藏
A new prognostic scoring system for newly diagnosed multiple myeloma in the era of new drugs新药时代新诊断多发性骨髓瘤的新预后评分系统
err2024-10-22
err0
errOAAI
errLi, Ye; Liu, Junru; Deng, Jingjing; Jian, Yuan; Zhang, Zhiyao; Zhou, Huixing; Li, Juan; Chen, Wenming
err分享
err收藏
Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients
err2024-09-17
err1
errOAAI
errJian, Yuan; Han, Feifei; Zhu, Ying; Geng, Chuanying; Zhang, Yanru; Wu, Yin; Leng, Yun; Chen, Wenming; An, Zhuoling; Zhu, Hong-Hu
err分享
err收藏
Nitrogen-Doped Carbon Dots: A New Powerful Fluorescent Dye with Substantial Effect on Bacterial Cell Labeling
err2024-08-15
err0
errOAAI
errLee, Sin-Jen; Zheng, Ya-Yun; Chen, Wen-Ming; Hsueh, Yi-Huang
err分享
err收藏
Structural and Mutational Analyses of Trehalose Synthase from Deinococcus radiodurans Reveal the Interconversion of Maltose-Trehalose Mechanism
err2024-08-07
err1
PREAI
errYe, Li-Ci; Chow, Sih-Yao; Chang, San-Chi; Kuo, Chia-Hung; Wang, Yung-Lin; Wei, Yong-Jun; Lee, Guan-Chiun; Liaw, Shwu-Huey; Chen, Wen-Ming; Chen, Sheng-Chia
err分享
err收藏
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 studysovleplenib (HMPL-523) 在中国 (ESLIM-01) 成人慢性原发性免疫性血小板减少症患者中的疗效和安全性: 一项随机,双盲,安慰剂对照的3期研究
err2024-08-01
err3
PREAI
errHu, Yu; Liu, Xiaofan; Zhou, Hu; Wang, Shujie; Huang, Ruibin; Wang, Yi; Du, Xin; Sun, Jing; Zhou, Zeping; Yan, Zhenyu; Chen, Wenming; Wang, Wei; Liu, Qingchi; Zeng, Qingshu; Gong, Yuping; Yin, Jie; Shen, Xuliang; Ye, Baodong; Chen, Yun; Xu, Yajing; Sun, Huiping; Cheng, Yunfeng; Liu, Zhuogang; Wang, Chunling; Yuan, Guolin; Zhang, Xiaohui; Li, Xin; Cheng, Peng; Guo, Xinhong; Jiang, Zhongxing; Yang, Feng'e; Yang, Linhua; Luo, Chengwei; Xiao, Taiwu; Fu, Sisi; Yin, Hongyan; Guo, Xiaojun; Xu, Qian; Fan, Songhua; Shi, Michael M.; Su, Weiguo; Mei, Heng; Yang, Renchi
err分享
err收藏
err分享
err收藏